stock
Avanos Medical Inc
NYSE | AVNS
12.72
USD
+0.00 (+0.00%)
AT CLOSE (AS OF Apr 29, 2025)
$593M
MARKET CAP
-
P/E Ratio
-8.4
EPS
$25
52 Week High
$12
52 Week Low
LIFE SCIENCES
Sector
AVNS Chart
1D
Area
-59.86%
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
AVNS Technicals
AVNS Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $381M |
| Total Revenue | $688M |
| Cost Of Revenue | $307M |
| Costof Goods And Services Sold | $307M |
| Operating Income | -$396M |
| Selling General And Administrative | $319M |
| Research And Development | $26M |
| Operating Expenses | $778M |
| Investment Income Net | - |
| Net Interest Income | -$7.1M |
| Interest Income | $5.1M |
| Interest Expense | $12M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $46M |
| Income Before Tax | -$403M |
| Income Tax Expense | -$17M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$386M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$391M |
| Ebitda | -$346M |
| Net Income | -$392M |
Revenue & Profitability
Earnings Performance
Actual: $undefined
Estimate: $undefined
Difference: $undefined
Period Qundefined
AVNS Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $1.2B |
| Total Current Assets | $393M |
| Cash And Cash Equivalents At Carrying Value | $108M |
| Cash And Short Term Investments | $108M |
| Inventory | $139M |
| Current Net Receivables | - |
| Total Non Current Assets | $761M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $112M |
| Intangible Assets Excluding Goodwill | $112M |
| Goodwill | $456M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $14M |
| Other Non Current Assets | - |
| Total Liabilities | $326M |
| Total Current Liabilities | $166M |
| Current Accounts Payable | - |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $20M |
| Total Non Current Liabilities | $160M |
| Capital Lease Obligations | $36M |
| Long Term Debt | $125M |
| Current Long Term Debt | $9.4M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $170M |
| Other Current Liabilities | $73M |
| Other Non Current Liabilities | $200K |
| Total Shareholder Equity | $829M |
| Treasury Stock | - |
| Retained Earnings | -$707M |
| Common Stock | $500K |
| Common Stock Shares Outstanding | $46M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $101M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $46M |
| Capital Expenditures | $18M |
| Change In Receivables | - |
| Change In Inventory | $39M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | -$49M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$13M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$392M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $381M |
| Total Revenue | $688M |
| Cost Of Revenue | $307M |
| Costof Goods And Services Sold | $307M |
| Operating Income | -$396M |
| Selling General And Administrative | $319M |
| Research And Development | $26M |
| Operating Expenses | $778M |
| Investment Income Net | - |
| Net Interest Income | -$7.1M |
| Interest Income | $5.1M |
| Interest Expense | $12M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $46M |
| Income Before Tax | -$403M |
| Income Tax Expense | -$17M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$386M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$391M |
| Ebitda | -$346M |
| Net Income | -$392M |
AVNS News
News Sentiment
The news sentiment chart shows the sentiment of news articles related to the symbol.
Avanos Medical Inc Top Stories
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Asure Software ( NASDAQ:ASUR ) , Algoma Steel Group ( NASDAQ:ASTL ) - 17 April 2025
AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK - 3 April 2025
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update - 31 March 2025
Avanos Medical ( AVNS ) Down 5.8% Since Last Earnings Report: Can It Rebound? - 28 March 2025
New Strong Sell Stocks for March 24th - 24 March 2025
New Strong Sell Stocks for March 18th - 18 March 2025
Do Options Traders Know Something About Avanos ( AVNS ) Stock We Don't? - 11 March 2025
New Strong Sell Stocks for March 3rd - 3 March 2025
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract - 27 February 2025
Avanos Medical ( AVNS ) Q4 Earnings and Revenues Surpass Estimates - 26 February 2025
Avanos Medical ( AVNS ) Soars 7.2%: Is Further Upside Left in the Stock? - 28 January 2025
Reasons to Hold Avanos Medical Stock in Your Portfolio Now - 23 January 2025
New Strong Sell Stocks for December 11th - 11 December 2024
CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View - 1 November 2024
Are Investors Undervaluing Avanos Medical ( AVNS ) Right Now? - 31 October 2024
Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts - 31 October 2024
CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View - 31 October 2024
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up - 30 October 2024
Avanos Medical ( AVNS ) Q3 Earnings Meet Estimates - 30 October 2024
Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y - 29 October 2024
TransMedics Stock Falls as Q3 Earnings & Sales Miss Estimates - 29 October 2024
West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance - 24 October 2024
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - 18 October 2024
Intuitive Surgical Q3 Earnings Beat, Procedures Robust - 18 October 2024
Avanos Medical ( AVNS ) Upgraded to Strong Buy: What Does It Mean for the Stock? - 17 October 2024
Global Enteral Feeding Devices Market is Projected to Evolve at a Modest 6.1% CAGR through 2031 | SkyQuest Technology - 11 October 2024
Should Value Investors Buy Avanos Medical ( AVNS ) Stock? - 9 October 2024
Reasons to Add Avanos Medical Stock in Your Portfolio Now - 3 October 2024
Implied Volatility Surging for Avanos ( AVNS ) Stock Options - 2 October 2024
Centene's Michigan Unit Partners With Mae to Reduce Health Disparities - 23 September 2024
Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy? - 19 September 2024
Are Investors Undervaluing Avanos Medical ( AVNS ) Right Now? - 19 September 2024
Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why - 18 September 2024
Avanos Medical Stock May Gain From Brand Partnership With NFL - 12 September 2024
Centene's Unit Secures New Four-Year Medicaid Contract in Iowa - 5 September 2024
Acadia Healthcare Expands Behavioral Health Services in Iowa - Acadia Healthcare Co ( NASDAQ:ACHC ) , Avanos Medical ( NYSE:AVNS ) - 28 August 2024
Acadia Healthcare Expands Behavioral Health Services in Iowa - 28 August 2024
( AVNS ) - Analyzing Avanos Medical's Short Interest - Avanos Medical ( NYSE:AVNS ) - 22 August 2024
Is Avanos Medical ( AVNS ) Stock Undervalued Right Now? - 22 August 2024
Implied Volatility Surging for Avanos ( AVNS ) Stock Options - 12 August 2024
Align Technology ( ALGN ) Encounters Low ASP, FX Headwinds - 6 August 2024
Should Value Investors Buy Avanos Medical ( AVNS ) Stock? - 5 August 2024
Is Phibro ( PAHC ) Stock Worth Retaining in Your Portfolio Now? - 5 August 2024
Avanos ( AVNS ) Q2 Earnings Top Estimates, Gross Margin Contracts - 1 August 2024
Avanos Medical ( AVNS ) Beats Q2 Earnings and Revenue Estimates - 31 July 2024
Three Reasons to Retain Avanos ( AVNS ) Stock in Your Portfolio - 26 July 2024
Globus Medical ( GMED ) Up 7.4% Since Last Earnings Report: Can It Continue? - 6 June 2024
Why Is Integra ( IART ) Up 26% Since Last Earnings Report? - 5 June 2024
Avanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply Chain - 13 May 2024
Avanos Medical ( NYSE:AVNS ) Upgraded to Buy at StockNews.com - 11 May 2024
AVNS Profile
Avanos Medical Inc Profile
Sector: LIFE SCIENCES
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Avanos Medical, Inc. is a medical technology company focused on providing medical device solutions to improve the quality of life for patients in North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is headquartered in Alpharetta, Georgia.
DMN 97.37%
$0.0075
LGMK 37.98%
$0.0178
WW 80.87%
$0.7479
PTPI -77.55%
$0.013
DGLY 12.10%
$0.0315
GNLN 3.33%
$0.0124
AGMH -23.58%
$0.1024
BON 12.46%
$0.0731
PLUG -5.82%
$0.9606
SOFI 1.92%
$13.4529
NVDA 0.49%
$109.26
AMCR -3.06%
$9.335
F 1.31%
$10.1508
CYCC 6.48%
$0.3038
PFE 3.21%
$23.79
TSLA 0.59%
$287.572
OMH 50.25%
$3.05
PLTR 1.36%
$116.213
LCID 0.79%
$2.55
DNN -3.08%
$1.415
AAL 0.51%
$9.9
SNAP 3.46%
$9.1359
LYT -16.78%
$0.0982
INTC -0.07%
$20.495
RIG -4.76%
$2.2
RIOT -2.75%
$7.42
WLDS 48.33%
$1.78
JBLU 2.70%
$4.18
AMZN -0.17%
$187.39
NIO -2.20%
$4.215
HOOD -1.05%
$48.93
MARA 1.39%
$14.205
NVNI 36.35%
$0.2112
HIMS 1.39%
$28.48
GRAB 0.63%
$4.79
BTE -3.92%
$1.595
ABEV 0.81%
$2.49
ITUB 1.45%
$6.3
BBD 1.88%
$2.435
CCL -0.82%
$18.705
AGNC 1.92%
$9.02
WULF -3.31%
$2.92
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
QBTS -5.70%
$6.9502
TLRY 2.71%
$0.4898
BTG 0.16%
$3.095
GOOGL -0.28%
$160.16
SMCI -2.87%
$36.1999
ONCO -4.88%
$0.0761
ERIC 0.78%
$8.3045
AZUL -0.49%
$0.8757
AAPL 0.67%
$211.54
SAG 42.57%
$1.44
WBD 0.80%
$8.77
APLD -4.34%
$4.5056
LYG 0.63%
$3.985
VALE 0.12%
$9.6112
WFC 2.50%
$71.169
ACHR 5.39%
$8.9899
PONY -8.19%
$9.475
OMEX 10.98%
$1.465
FNA 0.00%
$13.09
AMD -0.34%
$96.06
LFMD 38.03%
$8.42
BAC 0.69%
$40.055
CLSK -1.52%
$8.44
GM -0.77%
$46.8775
AEG -0.50%
$6.4971
RIVN 0.83%
$13.3
EJH -5.43%
$0.8701
IQ -0.53%
$1.88
AVTR 1.52%
$12.68
PBR 0.30%
$11.545
PYPL 2.25%
$66.3888
IXHL -75.49%
$0.1495
RGTI -3.59%
$8.8887
STLA 2.72%
$9.615
HTZ -13.34%
$7.375
NGD -0.89%
$3.34
KO 0.78%
$72.35
GOOG -0.22%
$162.06
RLMD -44.64%
$0.3571
VRN -1.62%
$6.09
T 0.20%
$27.3151
CDE -3.07%
$5.525
AG 0.56%
$6.275
IBIO 6.67%
$1.12
VZ 1.29%
$42.935
AREB -2.70%
$3.24
VOD 0.10%
$9.58
FUBO -0.96%
$3.1
BCS 1.10%
$16.145
ABEO -1.87%
$5.25
MSFT 0.74%
$394.04
OCEA -22.17%
$0.0066
HLN 0.30%
$10.2609
IONQ -0.69%
$28.7
AES 1.72%
$10.365
KVUE 1.17%
$23.38
DMN 97.37%
$0.0075
LGMK 37.98%
$0.0178
WW 80.87%
$0.7479
PTPI -77.55%
$0.013
DGLY 12.10%
$0.0315
GNLN 3.33%
$0.0124
AGMH -23.58%
$0.1024
BON 12.46%
$0.0731
PLUG -5.82%
$0.9606
SOFI 1.92%
$13.4529
NVDA 0.49%
$109.26
AMCR -3.06%
$9.335
F 1.31%
$10.1508
CYCC 6.48%
$0.3038
PFE 3.21%
$23.79
TSLA 0.59%
$287.572
OMH 50.25%
$3.05
PLTR 1.36%
$116.213
LCID 0.79%
$2.55
DNN -3.08%
$1.415
AAL 0.51%
$9.9
SNAP 3.46%
$9.1359
LYT -16.78%
$0.0982
INTC -0.07%
$20.495
RIG -4.76%
$2.2
RIOT -2.75%
$7.42
WLDS 48.33%
$1.78
JBLU 2.70%
$4.18
AMZN -0.17%
$187.39
NIO -2.20%
$4.215
HOOD -1.05%
$48.93
MARA 1.39%
$14.205
NVNI 36.35%
$0.2112
HIMS 1.39%
$28.48
GRAB 0.63%
$4.79
BTE -3.92%
$1.595
ABEV 0.81%
$2.49
ITUB 1.45%
$6.3
BBD 1.88%
$2.435
CCL -0.82%
$18.705
AGNC 1.92%
$9.02
WULF -3.31%
$2.92
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
QBTS -5.70%
$6.9502
TLRY 2.71%
$0.4898
BTG 0.16%
$3.095
GOOGL -0.28%
$160.16
SMCI -2.87%
$36.1999
ONCO -4.88%
$0.0761
ERIC 0.78%
$8.3045
AZUL -0.49%
$0.8757
AAPL 0.67%
$211.54
SAG 42.57%
$1.44
WBD 0.80%
$8.77
APLD -4.34%
$4.5056
LYG 0.63%
$3.985
VALE 0.12%
$9.6112
WFC 2.50%
$71.169
ACHR 5.39%
$8.9899
PONY -8.19%
$9.475
OMEX 10.98%
$1.465
FNA 0.00%
$13.09
AMD -0.34%
$96.06
LFMD 38.03%
$8.42
BAC 0.69%
$40.055
CLSK -1.52%
$8.44
GM -0.77%
$46.8775
AEG -0.50%
$6.4971
RIVN 0.83%
$13.3
EJH -5.43%
$0.8701
IQ -0.53%
$1.88
AVTR 1.52%
$12.68
PBR 0.30%
$11.545
PYPL 2.25%
$66.3888
IXHL -75.49%
$0.1495
RGTI -3.59%
$8.8887
STLA 2.72%
$9.615
HTZ -13.34%
$7.375
NGD -0.89%
$3.34
KO 0.78%
$72.35
GOOG -0.22%
$162.06
RLMD -44.64%
$0.3571
VRN -1.62%
$6.09
T 0.20%
$27.3151
CDE -3.07%
$5.525
AG 0.56%
$6.275
IBIO 6.67%
$1.12
VZ 1.29%
$42.935
AREB -2.70%
$3.24
VOD 0.10%
$9.58
FUBO -0.96%
$3.1
BCS 1.10%
$16.145
ABEO -1.87%
$5.25
MSFT 0.74%
$394.04
OCEA -22.17%
$0.0066
HLN 0.30%
$10.2609
IONQ -0.69%
$28.7
AES 1.72%
$10.365
KVUE 1.17%
$23.38
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.